BIODESIX, INC. (BDSX) Operating income 2019–2025
BIODESIX, INC. (BDSX) annual operating income history from SEC filings — each fiscal year as reported.
-$27.9MFY2025 · since FY2019: -$26.7M → -$27.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.9M | +19.2% |
| FY2024 | -$34.5M | +16.6% |
| FY2023 | -$41.3M | +18.3% |
| FY2022 | -$50.6M | -23.6% |
| FY2021 | -$40.9M | -78.5% |
| FY2020 | -$22.9M | +14.2% |
| FY2019 | -$26.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BDSX financial trends
BDSX RevenueBDSX Net incomeBDSX Net marginBDSX Gross profitBDSX Gross marginBDSX Operating marginBDSX Operating cash flowBDSX Free cash flowBDSX Capital expendituresBDSX Return on equityBDSX Stock buybacksBDSX Dividends paidBDSX Total assetsBDSX Total liabilitiesBDSX Shareholders’ equityBDSX overview →